Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease

NCT00683111 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Acute Myocardial Infarction

Interventions

DRUG: esomeprazole 20 mg daily
DRUG: famotidine 40 mg daily

Sponsor

Ruttonjee Hospital